연구동향 분석

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy

김희윤 김철응 배재남 이희원 정승호 이정섭 강민희 2014년

논문상세정보
인용/피인용
' Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • antipsychotic agents
  • polypharmacy
  • psychotropic drugs.
  • schizophrenia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
436 0

0.0%

' Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy' 의 참고문헌

  • 한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성(II): 적용상의 문제점 및 향후 개정 방향
    안용민 대한정신약물학회지 17 1 35-49 [2006]
  • 한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성 (I): 치료효과 측면에서의 분석
    배승오 대한정신약물학회지 17 1 24-34 [2006]
  • 정신분열병 환자에서 비정형 항정신병약물과 항콜린성 약물의 병합 사용：예비 연구
    우영섭 대한정신약물학회지 17 2 174-180 [2006]
  • 정신건강의학과 입원 환자의 항정신병약물 사용 변화: 일 대학병원에서 1997년, 2003~2004년과 2009~2010년의 비교
    심인희 대한정신약물학회지 23 2 57-64 [2012]
  • 일산화탄소 중독과 관련된 정신병적 증상 및 파킨슨 증상이 동반된 환자에서의 Aripiprazole 치료 1예
    김태석 대한정신약물학회지 16 2 163-168 [2005]
  • World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
    Hasan A World J Biol Psychiatry 13 318-378 [2012]
  • SOHO Study Group. The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia
    Haro JM Acta Psychiatr Scand Suppl 416 16-23 [2003]
  • Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia
    Patrick DL Curr Med Res Opin 25 325-338 [2009]
  • Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia
    Nasrallah H, Morosini P Psychiatry Res 161 213-224 [2008]
  • Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders
    Wang PS Schizophr Bull 26 451-457 [2000]
  • Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000
    Ganguly R J Clin Psychiatry 65 1377-1388 [2004]
  • Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009
    Gallego JA Schizophr Res 138 18-28 [2012]
  • Practice guideline for the treatment of patients with schizophrenia
    American Psychiatric Association Am J Psychiatry 154 1-63 [1997]
  • Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia
    Tiihonen J Arch Gen Psychiatry 69 476-483 [2012]
  • Pharmacotherapy for schizophrenic inpatients in East Asia-changes and challenges
    Shinfuku N Int Rev Psychiatry 20 460-468 [2008]
  • Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients
    Procyshyn RM J Clin Psychiatry 71 566-573 [2010]
  • Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients
    Paton C J Psychopharmacol 17 223-229 [2003]
  • Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy
    Santone G Pharmacoepidemiol Drug Saf 20 441-449 [2011]
  • Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits
    Centorrino F Am J Psychiatry 161 700-706 [2004]
  • High-cost use of second-generation antipsychotics under California's Medicaid program
    Stahl SM Psychiatr Serv 57 127-129 [2006]
  • Heterogeneity of violence in schizophrenia and implications for long-term treatment
    Volavka J Int J Clin Pract 62 1237-1245 [2008]
  • Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo
    Leucht S A meta-analysis of randomized controlled trials. Schizophr Res 35 51-68 [1999]
  • Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Correll CU Schizophr Res 89 91-100 [2007]
  • Description of long-term polypharmacy among schizophrenia outpatients
    Suokas JT Soc Psychiatry Psychiatr Epidemiol 48 631-638 [2013]
  • Current management of schizophrenia: antipsychotic monotherapy versus combination therapy
    Cascade EF Psychiatry (Edgmont) 5 28-30 [2008]
  • Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
    Fleischhacker WW Int J Neuropsychopharmacol 1-11 [2012]
  • Concomitant medication of psychoses in a lifetime perspective
    Vares M Hum Psychopharmacol 26 322-331 [2011]
  • Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life
    Voruganti L Schizophr Res 43 135-145 [2000]
  • Chlorpromazine equivalent doses for the newer atypical antipsychotics
    Woods SW. J Clin Psychiatry 64 663-667 [2003]
  • Antipsychotics Prescribing Patterns of Patients with Schizophrenia Admitted to Korean General Hospital Psychiatric Unit: 2001 to 2008
    Hye Jin Choi Clinical Psychopharmacology and Neuroscience 9 1 17-22 [2011]
  • Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004
    Gilmer TP Psychiatr Serv 58 1007-1010 [2007]
  • Antipsychotic polypharmacy in patients with schizophrenia:a multicentre comparative study in East Asia
    Sim K Br J Clin Pharmacol 58 178-183 [2004]
  • Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009)
    Xiang YT Pharmacopsychiatry 45 7-12 [2012]
  • Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change
    Chong MY Psychiatry Clin Neurosci 58 61-67 [2004]
  • Antipsychotic combinations vs monotherapy in schizophrenia:a meta-analysis of randomized controlled trials
    Correll CU Schizophr Bull 35 443-457 [2009]
  • American Psychiatric Association;Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition
    Lehman AF Am J Psychiatry 161 2Suppl 1-56 [2004]
  • A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation
    Stahl SM Curr Med Chem 11 313-327 [2004]